##gff-version 3
##sequence-region Q6F5E8 1 1435
Q6F5E8	UniProtKB	Chain	1	1435	.	.	.	ID=PRO_0000325817;Note=Capping protein%2C Arp2/3 and myosin-I linker protein 2	
Q6F5E8	UniProtKB	Repeat	64	88	.	.	.	Note=LRR 1	
Q6F5E8	UniProtKB	Repeat	89	111	.	.	.	Note=LRR 2	
Q6F5E8	UniProtKB	Repeat	249	272	.	.	.	Note=LRR 3	
Q6F5E8	UniProtKB	Repeat	274	297	.	.	.	Note=LRR 4	
Q6F5E8	UniProtKB	Repeat	303	326	.	.	.	Note=LRR 5	
Q6F5E8	UniProtKB	Repeat	335	362	.	.	.	Note=LRR 6	
Q6F5E8	UniProtKB	Repeat	393	423	.	.	.	Note=LRR 7	
Q6F5E8	UniProtKB	Repeat	429	452	.	.	.	Note=LRR 8	
Q6F5E8	UniProtKB	Repeat	461	481	.	.	.	Note=LRR 9	
Q6F5E8	UniProtKB	Repeat	492	514	.	.	.	Note=LRR 10	
Q6F5E8	UniProtKB	Repeat	519	543	.	.	.	Note=LRR 11	
Q6F5E8	UniProtKB	Repeat	546	572	.	.	.	Note=LRR 12	
Q6F5E8	UniProtKB	Repeat	581	604	.	.	.	Note=LRR 13	
Q6F5E8	UniProtKB	Repeat	608	631	.	.	.	Note=LRR 14	
Q6F5E8	UniProtKB	Repeat	636	660	.	.	.	Note=LRR 15	
Q6F5E8	UniProtKB	Repeat	664	687	.	.	.	Note=LRR 16	
Q6F5E8	UniProtKB	Region	573	667	.	.	.	Note=Tropomodulin-like	
Q6F5E8	UniProtKB	Region	1087	1114	.	.	.	Note=Necessary for localization at the cell membrane;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26578515;Dbxref=PMID:26578515	
Q6F5E8	UniProtKB	Compositional bias	905	1046	.	.	.	Note=Pro-rich	
Q6F5E8	UniProtKB	Compositional bias	1311	1435	.	.	.	Note=Pro-rich	
Q6F5E8	UniProtKB	Modified residue	991	991	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:23186163,PMID:24275569	
Q6F5E8	UniProtKB	Modified residue	993	993	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19690332;Dbxref=PMID:19690332	
Q6F5E8	UniProtKB	Modified residue	1120	1120	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q3V3V9	
Q6F5E8	UniProtKB	Modified residue	1246	1246	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19690332;Dbxref=PMID:19690332	
Q6F5E8	UniProtKB	Modified residue	1303	1303	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q3V3V9	
Q6F5E8	UniProtKB	Modified residue	1315	1315	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q3V3V9	
Q6F5E8	UniProtKB	Modified residue	1420	1420	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q3V3V9	
Q6F5E8	UniProtKB	Alternative sequence	384	419	.	.	.	ID=VSP_047857;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:19846667;Dbxref=PMID:19846667	
Q6F5E8	UniProtKB	Alternative sequence	1346	1372	.	.	.	ID=VSP_047858;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:19846667;Dbxref=PMID:19846667	
Q6F5E8	UniProtKB	Natural variant	50	50	.	.	.	ID=VAR_081149;Note=In IMD58%3B decreased protein expression in patient's cells. R->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29479355;Dbxref=PMID:29479355	
Q6F5E8	UniProtKB	Natural variant	372	372	.	.	.	ID=VAR_081150;Note=In IMD58%3B decreased protein expression in patient's leukocytes%3B no effect on homodimerization. L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27647349;Dbxref=PMID:27647349	
Q6F5E8	UniProtKB	Natural variant	525	525	.	.	.	ID=VAR_081151;Note=In IMD58%3B decreased protein expression in patient's leukocytes%3B no effect on homodimerization. L->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27647349;Dbxref=PMID:27647349	
Q6F5E8	UniProtKB	Natural variant	639	639	.	.	.	ID=VAR_081152;Note=In IMD58. L->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27896283;Dbxref=dbSNP:rs775061512,PMID:27896283	
Q6F5E8	UniProtKB	Natural variant	853	1435	.	.	.	ID=VAR_081153;Note=In IMD58%3B no detectable protein expression in patient's leukocytes%3B no effect on homodimerization. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27647349;Dbxref=PMID:27647349	
Q6F5E8	UniProtKB	Mutagenesis	1021	1021	.	.	.	Note=Loss of ability to bind heterodimeric capping protein (CP)%2C unable to inhibit the actin-capping activity of CP and to rescue the loss of lamellipodial ruffling%2C macropinocytosis%2C cell polarity%2C and invadopodia-mediated matrix degradation%3B when associated with A-1023. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26466680;Dbxref=PMID:26466680	
Q6F5E8	UniProtKB	Mutagenesis	1023	1023	.	.	.	Note=Loss of ability to bind heterodimeric capping protein (CP)%2C unable to inhibit the actin-capping activity of CP and to rescue the loss of lamellipodial ruffling%2C macropinocytosis%2C cell polarity%2C and invadopodia-mediated matrix degradation%3B when associated with A-1021. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26466680;Dbxref=PMID:26466680	
Q6F5E8	UniProtKB	Mutagenesis	1096	1106	.	.	.	Note=Loss of accumulation at the cell membrane. Does not alter colocalization at vimentin filaments. Alters monopolar cell polarity%2C increasing the number of leading edges lacking lamellipodia and ruffles. Inhibits cell migration during wound healing. KKLGTLFAFKK->EEEEEEEEEEE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26578515;Dbxref=PMID:26578515	
Q6F5E8	UniProtKB	Mutagenesis	1096	1106	.	.	.	Note=Loss of accumulation at the cell membrane. Does not alter colocalization at vimentin filaments. Alters monopolar cell polarity%2C increasing the number of leading edges lacking lamellipodia and ruffles. Inhibits cell migration during wound healing. KKLGTLFAFKK->GGGGGGGGGGG;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26578515;Dbxref=PMID:26578515	
Q6F5E8	UniProtKB	Mutagenesis	1096	1106	.	.	.	Note=Loss of accumulation at the cell membrane. Does not alter colocalization at vimentin filaments. Alters monopolar cell polarity%2C increasing the number of leading edges lacking lamellipodia and ruffles. Inhibits cell migration during wound healing. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26578515;Dbxref=PMID:26578515	
